Financhill
Sell
50

ARES Quote, Financials, Valuation and Earnings

Last price:
$147.81
Seasonality move :
6.3%
Day range:
$144.48 - $149.05
52-week range:
$125.23 - $200.49
Dividend yield:
2.65%
P/E ratio:
72.76x
P/S ratio:
5.63x
P/B ratio:
14.71x
Volume:
1.7M
Avg. volume:
1.6M
1-year change:
8.15%
Market cap:
$30.7B
Revenue:
$5.2B
EPS (TTM):
$2.03

Analysts' Opinion

  • Consensus Rating
    Ares Management has received a consensus rating of Hold. The company's average rating is a Hold based on 4 Buy ratings, 6 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $194.23, Ares Management has an estimated upside of 31.5% from its current price of $147.71.
  • Price Target Downside
    According to analysts, the lowest downside price target is $164.00 representing -11.03% downside risk from its current price of $147.71.

Fair Value

  • According to the consensus of 10 analysts, Ares Management has 31.5% upside to fair value with a price target of $194.23 per share.

ARES vs. S&P 500

  • Over the past 5 trading days, Ares Management has overperformed the S&P 500 by 2.58% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Ares Management does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Ares Management has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Ares Management reported revenues of $1.6B.

Earnings Growth

  • Ares Management earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Ares Management reported earnings per share of $0.72.
Enterprise value:
45.2B
EV / Invested capital:
--
Price / LTM sales:
5.63x
EV / EBIT:
20.04x
EV / Revenue:
8.70x
PEG ratio (5yr expected):
4.66x
EV / Free cash flow:
16.73x
Price / Operating cash flow:
10.84x
Enterprise value / EBITDA:
20.04x
Gross Profit (TTM):
$3.5B
Return On Assets:
1.89%
Net Income Margin (TTM):
8.93%
Return On Equity:
8.82%
Return On Invested Capital:
2.38%
Operating Margin:
38.97%
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Income Statement
Revenue $3.7B $5B $5.2B $1.5B $1.6B
Gross Profit $2.2B $3.5B $3.5B $1.1B $1.1B
Operating Income $980.4M $2.2B $2.3B $720.3M $626.3M
EBITDA $993.5M $2.2B $2.3B $726.2M $646.4M
Diluted EPS $0.87 $2.39 $2.03 $0.86 $0.72
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Balance Sheet
Current Assets $1.7B $2.6B $2.2B $2.8B $4.2B
Total Assets $15.2B $21.6B $22B $24.7B $24.9B
Current Liabilities $1.7B $4B $3.4B $3.8B $4.3B
Total Liabilities $12.7B $17.8B $18.2B $20.3B $18.1B
Total Equity $2.5B $3.8B $3.8B $4.5B $6.8B
Total Debt $10.7B $12.3B $13.1B $15.4B $12.5B
Trailing 12 Months Fiscal Quarters
Period Ending 2022-12-31 2023-12-31 2024-12-31 2023-12-31 2024-12-31
Cash Flow Statement
Cash Flow Operations -$734.1M -$233.3M $2.8B -$560.1M $807.6M
Cash From Investing -$337.4M -$111.1M -$159.4M -$66.9M -$63.5M
Cash From Financing $1.1B $292.1M -$1.4B $633.7M $478.2M
Free Cash Flow -$769.9M -$300.4M $2.7B -$583.1M $798.3M
ARES
Sector
Market Cap
$30.7B
$616.2M
Price % of 52-Week High
73.68%
85.86%
Dividend Yield
2.65%
1.99%
Shareholder Yield
--
3.77%
1-Year Price Total Return
8.15%
8.45%
Beta (5-Year)
1.233
0.714
Dividend yield:
2.65%
Annualized payout:
$3.72
Payout ratio:
282.68%
Growth streak:
5 years

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Technicals

8-day SMA
Buy
Level $145.53
200-day SMA
Sell
Level $160.20
Bollinger Bands (100)
Sell
Level 161.47 - 188.25
Chaikin Money Flow
Buy
Level 89.7M
20-day SMA
Sell
Level $156.88
Relative Strength Index (RSI14)
Sell
Level 37.00
ADX Line
Sell
Level 41.29
Williams %R
Neutral
Level -65.8836
50-day SMA
Sell
Level $175.89
MACD (12, 26)
Sell
Level -9.52
25-day Aroon Oscillator
Sell
Level -68
On Balance Volume
Neutral
Level 75.7M

Financial Scores

Sell
Altman Z-Score (Annual)
Level (1.7008)
Sell
CA Score (Annual)
Level (-1.7666)
Buy
Beneish M-Score (Annual)
Level (-2.2752)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (0.6232)
Buy
Piotroski F Score (Annual)
Level (6)
Sell
Quality Ratio Score
Level (2)
Buy
Fundamental Score
Level (8)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Ares Management Corp is an asset management company. It offers investors investment-related advice and strategies for capital growth. The company's operating segments include Credit Group, Private Equity Group, Real Assets, Secondaries Group, and Others. Its Credit Group generates maximum revenue and manages credit strategies across the liquid and illiquid spectrum. Private Equity Group manages investment strategies categorized as corporate private equity, infrastructure and power, and special opportunities, Real Estate Group manages comprehensive equity and debt strategies across real estate & infrastructure investments. The Secondaries Group invests in secondary markets across a range of alternative asset class strategies, including private equity, real estate, infrastructure, & credit.

Stock Forecast FAQ

In the current month, ARES has received 4 Buy ratings 6 Hold ratings, and 0 Sell ratings. The ARES average analyst price target in the past 3 months is $194.23.

  • Where Will Ares Management Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Ares Management share price will rise to $194.23 per share over the next 12 months.

  • What Do Analysts Say About Ares Management?

    Analysts are divided on their view about Ares Management share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Ares Management is a Sell and believe this share price will drop from its current level to $164.00.

  • What Is Ares Management's Price Target?

    The price target for Ares Management over the next 1-year time period is forecast to be $194.23 according to 10 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 6 analysts rate the stock a Hold.

  • Is ARES A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Ares Management is a Hold. 6 of 10 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of ARES?

    You can purchase shares of Ares Management via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Ares Management shares.

  • What Is The Ares Management Share Price Today?

    Ares Management was last trading at $147.81 per share. This represents the most recent stock quote for Ares Management. Yesterday, Ares Management closed at $147.71 per share.

  • How To Buy Ares Management Stock Online?

    In order to purchase Ares Management stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is CyberArk Stock a Buy, Sell or Hold?
Is CyberArk Stock a Buy, Sell or Hold?

CyberArk Software (NASDAQ:CYBR), the identity security and management firm, has…

Is Amazon Stock Still Worth Staking On?
Is Amazon Stock Still Worth Staking On?

Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…

Is Palantir a Good Stock to Buy?
Is Palantir a Good Stock to Buy?

Palantir Technologies (PLTR) stock soared to its highest level in…

Stock Ideas

Buy
55
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Sell
50
RGC alert for Mar 22

Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.

Sell
36
VMI alert for Mar 22

Valmont Industries [VMI] is down 12.54% over the past day.

Buy
61
ALNY alert for Mar 22

Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock